Skip to Main Content Skip to Site Map Skip to Accessibility Statement

REFRACT

May 16, 2025
Trial REFRACT
Cancer Type Haematological Cancers and Lymphoma
Hospital(s) Belfast City Hospital
Information

A randomised phase II trial of investigator choice standard therapy versus sequential novel therapy experimental arms in relapsed and refractory follicular lymphoma

Click Here to view Cancer Research UK trial summary